Kinetics Mutual Funds, Inc. The Medical Fund (MEDRX)
Kinetics Mutual Funds, Inc. The Medical Fund operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY. The stock last traded at $31.22, up 0.00% on the session, giving a market capitalisation of $19.4M. Its beta of 0.51 implies it has historically moved less than the broad market.
Kinetics Mutual Funds, Inc. The Medical Fund operates as a non-diversified investment vehicle, allocating all of its capital exclusively to the Medical Portfolio, a specific series within the Kinetics Portfolios Trust. The Medical Portfolio is strategically mandated to invest a minimum of 80% of its net assets—inclusive of any funds borrowed for investment purposes—into a range of equity and equity-linked securities. These include common shares, convertible debt instruments, warrants, and other securities sharing characteristics with common stock. The target companies, both domestic and international, are primarily engaged across medical research, pharmaceutical, and medical technology sectors, as well as associated technology industries. A significant emphasis is placed on entities dedicated to cancer research and the development of new drugs.
Kinetics Mutual Funds, Inc. The Medical Fund is most often compared with the following Financial Services names: